Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2006

01-08-2006 | Original Paper

Validation of a comprehensive classification tool for treatment-related problems

Authors: Salah M. AbuRuz, Nailya R. Bulatova, Almoatasem M. Yousef

Published in: International Journal of Clinical Pharmacy | Issue 4/2006

Login to get access

Abstract

Objective

Several drug-related problem classification systems can be found in the literature. However, it is generally agreed that a comprehensive, well constructed and validated instrument is currently lacking. The aim of this study is the development and validation of a comprehensive treatment-related problems assessment and classification tool for use in teaching, practicing and researching pharmaceutical care and to improve identification, resolving and preventing of treatment-related problems.

Method

The development and validation involved five steps starting with literature search to define a treatment related problem and also to form a database of treatment-related problems identified in the literature. In the next step, all problems that were identified in the first step and passed the evaluation of the three authors were pooled together and then divided into groups according to their common or shared construct, in the third step a suitable assessment method was developed according to the construct of the different problems, in the next step the developed instrument was validated for content, internal and external validity. Finally the tool was finalized and tested for reproducibility and inter-rater agreement.

Results

The final validated version included six main categories for treatment-related problems (Indication, Effectiveness, Safety, Knowledge, Adherence and Miscellaneous). These categories include a total of nine subcategories and a total of 29 treatment related problems.

Conclusion

The treatment-related problems assessment and classification tool introduced in this paper was applied to actual patient cases and proved to be valid. This tool also has several features that are new.
Literature
1.
go back to reference Hepler CD, Srand LM. Opportunities and responsibilities in Pharmaceutical Care. Am J Hosp Pharm 1990;47:533–43.PubMed Hepler CD, Srand LM. Opportunities and responsibilities in Pharmaceutical Care. Am J Hosp Pharm 1990;47:533–43.PubMed
2.
go back to reference ASHP guidelines on a standardized method for pharmaceutical care. Am J Health Syst Pharm 1996;53:1713–6. ASHP guidelines on a standardized method for pharmaceutical care. Am J Health Syst Pharm 1996;53:1713–6.
3.
go back to reference American Society of Hospital Pharmacists. ASHP statement on pharmaceutical care. Am J Hosp Pharm 1993;50:1720–3. American Society of Hospital Pharmacists. ASHP statement on pharmaceutical care. Am J Hosp Pharm 1993;50:1720–3.
4.
go back to reference National Academy of Sciences Institute of Medicine. To err is human. Washington, DC: National Academy Press; 1999. National Academy of Sciences Institute of Medicine. To err is human. Washington, DC: National Academy Press; 1999.
5.
go back to reference Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. J Am Hosp Pharm 1992;49:1696–700. Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. J Am Hosp Pharm 1992;49:1696–700.
6.
go back to reference Hallas J, Gram LF, Grodum E. Drug-related admissions to medical wards: a population based survey. Br J Clin Phamacol 1992;33:61–8. Hallas J, Gram LF, Grodum E. Drug-related admissions to medical wards: a population based survey. Br J Clin Phamacol 1992;33:61–8.
7.
go back to reference Pirmohamed M, Breckenridge M, Kitteringham NR, Park BK. Adverse drug reactions. Br Med J 1998;316:1295–8. Pirmohamed M, Breckenridge M, Kitteringham NR, Park BK. Adverse drug reactions. Br Med J 1998;316:1295–8.
8.
go back to reference Schneider PJ, Gift M. Cost of medication errors. Int Pharm J 1996;10:S1–11. Schneider PJ, Gift M. Cost of medication errors. Int Pharm J 1996;10:S1–11.
9.
go back to reference Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832–40.PubMed Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993;27:832–40.PubMed
10.
go back to reference Neville RG, Robertson F, Livingstone S, Crombie IK. A classification of prescription errors. J Roy Coll Gen Pract 1989;39:110–2 Neville RG, Robertson F, Livingstone S, Crombie IK. A classification of prescription errors. J Roy Coll Gen Pract 1989;39:110–2
11.
12.
go back to reference Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Ann Intern Med 1995;155:1949–56.CrossRef Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Ann Intern Med 1995;155:1949–56.CrossRef
13.
go back to reference Van Mil JW, Westerlund TLO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859–67.PubMedCrossRef Van Mil JW, Westerlund TLO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859–67.PubMedCrossRef
14.
go back to reference Currie JD, Doucette WR, Kuhle J, Sobotka J, Miller WA, McDonough RP, et al. Identification of essential elements in the documentation of pharmacist-provided care. J Am Pharm Assoc 2003;43:41–9.CrossRef Currie JD, Doucette WR, Kuhle J, Sobotka J, Miller WA, McDonough RP, et al. Identification of essential elements in the documentation of pharmacist-provided care. J Am Pharm Assoc 2003;43:41–9.CrossRef
15.
go back to reference Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998. ISBN 0070120463. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998. ISBN 0070120463.
16.
go back to reference Pharmaceutical Care Network Europe. PCNE Classification for drug related problems v5.00. In drug related problems, Pharmaceutical Care Network Europe. http://www.pcne.org/dokumenter/PCNE%20classification%20V5.00.pdf (01 Nov. 2005). Pharmaceutical Care Network Europe. PCNE Classification for drug related problems v5.00. In drug related problems, Pharmaceutical Care Network Europe. http://​www.​pcne.​org/​dokumenter/​PCNE%20classification%20V5.00.pdf (01 Nov. 2005).
17.
18.
go back to reference Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045–51.PubMedCrossRef Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992;45:1045–51.PubMedCrossRef
19.
go back to reference Van Mil JWF, Tromp ThFJ. Coding frequently asked questions during the pharmaceutical care process with the Pas System. J Appl Ther 1997;1:351–5. Van Mil JWF, Tromp ThFJ. Coding frequently asked questions during the pharmaceutical care process with the Pas System. J Appl Ther 1997;1:351–5.
20.
go back to reference Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002;24:120–7.PubMedCrossRef Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002;24:120–7.PubMedCrossRef
21.
go back to reference Krska J, Jamieson D, Arris F, McGuire A, Abbott S, Hansford D, et al. A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract 2002;10:91–100. Krska J, Jamieson D, Arris F, McGuire A, Abbott S, Hansford D, et al. A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract 2002;10:91–100.
22.
go back to reference Llimos F, Faus M. From “drug-related problems" to “negative clinical outcomes". Am J Hosp Pharm 2005;62:2348–50. Llimos F, Faus M. From “drug-related problems" to “negative clinical outcomes". Am J Hosp Pharm 2005;62:2348–50.
23.
go back to reference Consensus Committee. Second consensus of granada on drug therapy problems. Ars Pharm 2002;43:179–87. Consensus Committee. Second consensus of granada on drug therapy problems. Ars Pharm 2002;43:179–87.
Metadata
Title
Validation of a comprehensive classification tool for treatment-related problems
Authors
Salah M. AbuRuz
Nailya R. Bulatova
Almoatasem M. Yousef
Publication date
01-08-2006
Publisher
Kluwer Academic Publishers
Published in
International Journal of Clinical Pharmacy / Issue 4/2006
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-006-9048-0

Other articles of this Issue 4/2006

International Journal of Clinical Pharmacy 4/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine